{"gao_id": "GAO-20-34", "published": "2019-10-17T12:00:00Z", "released": "2019-11-18T07:00:00Z", "summary": "The Food and Drug Administration charges tobacco manufacturers a fee to fund regulation activities (such as educating the public about risks associated with tobacco). These fees, which are based on companies\u2019 market shares, were about $635 million in FY 2017. FDA is supposed to check its fee calculations and make adjustments at the end of each year, but the most recent adjustment was completed for...", "title": "Tobacco User Fees: Further Action Needed to Ensure Calculations Are Based on Complete and Accurate Data", "topics": ["Reconciliation process", "Compliance oversight", "Tobacco products", "Smoking", "Health care standards", "Market share", "User fees", "Alcohol and tobacco taxes", "Health Care", "Deaths", "Excise taxes"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-34", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-20-34-highlights.pdf"}, {"title": "Full Report (37 pages)", "url": "https://www.gao.gov/assets/gao-20-34.pdf"}, {"title": "Accessible PDF (45 pages)", "url": "https://www.gao.gov/assets/710/705796.pdf"}]}